Compounds > sr 48692
Page last updated: 2024-09-03

sr 48692 and Pancreatic Neoplasms

sr 48692 has been researched along with Pancreatic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Ehata, S; Miyauchi, K; Miyazawa, K; Miyazono, K; Morishita, Y; Takahashi, K1
Cui, L; Li, HN; Li, NN; Wang, JG; Wang, P1
Momose, K; Ohata, H; Richelson, E; Yamada, M1
Evers, BM; Gully, D; Hellmich, MR; Higashide, S; Iwase, K; Kim, HJ; Thompson, JC; Townsend, CM1

Other Studies

4 other study(ies) available for sr 48692 and Pancreatic Neoplasms

ArticleYear
Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
    Molecular oncology, 2021, Volume: 15, Issue:1

    Topics: Animals; Carcinogenesis; Cell Line, Tumor; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Humans; MAP Kinase Signaling System; Mice, Inbred BALB C; Neoplasm Metastasis; NF-kappa B; Pancreatic Neoplasms; Pyrazoles; Quinolines; Receptors, Neurotensin; Signal Transduction

2021
Pancreatic cancer bears overexpression of neurotensin and neurotensin receptor subtype-1 and SR 48692 counteracts neurotensin induced cell proliferation in human pancreatic ductal carcinoma cell line PANC-1.
    Neuropeptides, 2011, Volume: 45, Issue:2

    Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Female; Humans; Male; Neurotensin; Pancreatic Neoplasms; Pyrazoles; Quinolines; Receptors, Neurotensin

2011
Pharmacological characterization of SR 48692 sensitive neurotensin receptor in human pancreatic cancer cells, MIA PaCa-2.
    Research communications in molecular pathology and pharmacology, 1995, Volume: 90, Issue:1

    Topics: Calcium; Cloning, Molecular; Humans; Neurotensin; Pancreatic Neoplasms; Pyrazoles; Quinolines; Receptors, Neurotensin; Tumor Cells, Cultured

1995
Inhibition of neurotensin-induced pancreatic carcinoma growth by a nonpeptide neurotensin receptor antagonist, SR48692.
    Cancer, 1997, May-01, Volume: 79, Issue:9

    Topics: Animals; Binding Sites; Calcium; Cell Division; Drug Interactions; Humans; Hydrolysis; Intestine, Small; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neurotensin; Pancreatic Neoplasms; Phosphatidylinositol 4,5-Diphosphate; Pyrazoles; Quinolines; Receptors, Neurotensin; RNA, Messenger; Transplantation, Heterologous; Tumor Cells, Cultured

1997